Versant Venture Management »

Skye Bioscience shares owned by Versant Venture Management

Quarter-by-quarter ownership of Skye Bioscience (SKYE) shares owned by Versant Venture Management from 13F filings

Historical chart of Versant Venture Management investment in Skye Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Skye Bioscience held by Versant Venture Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Skye Bioscience by Versant Venture Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.9M 2.0M 3.91
2024-06-30 $16M 2.0M 8.01
2024-03-31 $31M 2.0M 15.64

More positions owned by Versant Venture Management

CRISPR Therapeutics Common Shares (CRSP)
Contineum Therapeutics Common Stock (CTNM)
Repare Therapeutics Common Stock (RPTX)
Skye Bioscience Common Stock (SKYE)
Adverum Biotechnologies Common Stock
Gritstone Oncology Common Stock (GRTS)

View all positions for Versant Venture Management

Top funds holding Skye Bioscience

5AM Venture Management
Versant Venture Management
Baker Bros. Advisors
Altium Capital Management
Logos Global Management
Sphera Funds Management
BlackRock
BlackRock
Schonfeld Strategic Advisors
Henderson Group
Ensign Peak Advisors
Vanguard Group
CVI Holdings
Driehaus Capital Management
Alyeska Investment Group

View all funds holding Skye Bioscience